Europe — EMA
Onsetrogen Mylan (Ondansetron)
Ondansetron, the active ingredient in Onsetrogen Mylan, is a serotonin 5‑HT3 receptor antagonist presented as a tablet for oral use. It is used to prevent nausea and vomiting associated with chemotherapy, radiotherapy…
Request sourcing
What is Ondansetron?
Ondansetron, the active ingredient in Onsetrogen Mylan, is a serotonin 5‑HT3 receptor antagonist presented as a tablet for oral use. It is used to prevent nausea and vomiting associated with chemotherapy, radiotherapy and postoperative recovery in adult and pediatric patients.
GNH USA supplies Onsetrogen Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Ondansetron used for?
Onsetrogen Mylan contains ondansetron, a medication that acts on the serotonergic pathway to control emesis. - Chemotherapy‑induced nausea and vomiting: helps reduce the frequency and severity of acute and delayed episodes. - Radiotherapy‑induced nausea and vomiting: provides prophylactic control of nausea during and after radiation treatment. - Post‑operative nausea and vomiting: reduces the incidence of nausea and vomiting following surgical procedures.
What are the side effects of Ondansetron?
Side effects reported with ondansetron are generally mild to moderate and vary with individual tolerance.
Common Side Effects: - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Diarrhoea: loose stools. - Fatigue: feeling of tiredness. - Dizziness: light‑headed sensation.
Serious or Rare Side Effects: - Cardiac arrhythmia: QT‑interval prolongation. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Serotonin syndrome: agitation, hyperreflexia, tremor, or fever. - Hepatic dysfunction: elevated liver enzymes. - Vision changes: blurred vision or visual disturbances.
What precautions apply to Ondansetron?
When using Onsetrogen Mylan, consider the following precautions to ensure safe use. - Cardiac monitoring: patients with known QT prolongation or electrolyte imbalance should be monitored. - Electrolyte balance: correct hypokalaemia or hypomagnesemia before initiating therapy. - Pregnancy: use only if the potential benefit outweighs the risk; discuss with a prescriber. - Breastfeeding: assess risk‑benefit before continuation. - Concomitant serotonergic drugs: evaluate for additive serotonin effects. - Store at ambient temperature: keep in the original container, protect from moisture and light.
What does Ondansetron interact with?
Ondansetron may interact with several medicines, altering its efficacy or safety profile.
Major Interactions (Avoid): - Apomatinib? (???) ???. - Medications ??? ?? ");
Moderate ");
- ");";
- ");".
- ");".
- "); ".
- " ".
- " ".
- ");.
- ");.
- ",
Product details
Related products

Ondansetron 2 mg/mL
Ondansetron · 2 mg/mL

Ondansetron 2 mg/mL
Ondansetron · 2 mg/mL

Ondansetron 2 mg/mL
Ondansetron · 2 mg/mL

ONDANSETRON 2 mg/mL
Ondansetron · 2 mg/mL